Scientific Updates for the Psychedelics Industry

Psychedelics News

Science

Industry, Science

30 Nov 2022

New MindMed Study Shortens Trip with “LSD-Neutralizer”

MindMed collaborators published a paper showing that the administration of ketanserin, effectively ends LSD’s psychedelic experience within 2....

By James Hallifax

Science

23 Nov 2022

New Study Shows Psychedelics Lowers Barriers to Higher Brain States

A recent study conducted by Cornell University has shown that psychedelics might lower the energy threshold brain networks require in order to shift to different configurations....

By Elisabetta Fato

Science

22 Nov 2022

Psychedelic Research Round-Up, by Blossom

By Floris Wolswijk

Science

17 Nov 2022

Predicting Psychedelic Outcomes

Can we better predict psychedelic outcomes? Imagine psychedelic settings curated to the individual, the right therapist, music, and even substance....

By Patrick McConnell

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry, Science

20 Oct 2022

A Deeper Look at Ketamine and its Potential for Addiction

Ketamine might be the current poster child for psychedelic medicine, but mainstream media has been missing an important reality about ketamine's divergence and potential for addiction....

By Patrick McConnell

Science

18 Oct 2022

Can LSD Make You Smarter? New Study Shows Positive Results

Humans are always on the hunt for life hacks, whether it’s getting fitter, slimmer, or more beautiful....

By Emma Stone

Science

14 Oct 2022

Psychedelic Research Round-Up, by Blossom

By Floris Wolswijk

Science

5 Oct 2022

New Study Shows Physical Healing Potential of Ayahuasca

A recent study showed the regenerative properties and wound healing of ayahuasca and were investigated in vitro....

By Elisabetta Fato

Industry, Science

4 Oct 2022

Is Ketamine Telehealth Here to Stay?

Ketamine telehealth has been booming....

By Patrick McConnell

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result